DIMS Institute of Medical Science, Inc.

Developers of Medium-term Carcinogenesis Bioassays in the world. / Contract safety research facility.

Mission

HOME ≫ Animal welfare ≫

Animal welfare

Animal welfare

Animal experiment studies are essential for estimating the safety and effect of pharmaceutic, etc. They are strictly acquired 3Rs (replacement, reduction and refinement).

They are performed in accordance with Act on Welfare and Management of Animals (Act No. 46; May, 2014), Standards Relating to the Care and Management of Laboratory Animals and Relief of Pain in the Ministry of the Environment (Notice No. 84; September, 2013), Basic policies for the conduct of animal experimentation in the Ministry of Health, Labor and Welfare (Notice No. 0220-1; February, 2015), Basic policies for the conduct of animal experimentation in the Ministry of Agriculture, Forestry and Fisheries (Notice No. 18 Nou-Kai 307; June, 2006), Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan; June, 2006), and the Standards for Care and Use of Laboratory Animals of the DIMS Institute of Medical Science, Inc. (December, 2018).

 

Their protocols are judged and approved by the Institutional Animal Care and Use Committee of the DIMS Institute of Medical Science, Inc. based on ethical and scientific perspective.

 

Animal experiment studies are routinely inspected and the results are reported.

Internal evaluation/judgement for proper conduct of animal experiment is annually executed by Self-Evaluation/Judgement Committee.

Internal evaluation/judgement

On July 2018, animal experiment studies in our laboratory are judged by Self-Evaluation/Judgement Committee in accordance with concerning ordinances and the internal standards.

Internal standards for animal experiment in our laboratory

1. Standards for Care and Use of Laboratory Animals of the DIMS Institute of 

    Medical Science, Inc. (December 17th, 2018)

2. Rules for Institutional Animal Care and Use Committee (December 17th, 2018)

3. Standard of study using gene-engineering animals (June 1st, 2018)

4. Standard of safety management for using gene-engineering animals

    (June 1st, 2018)

5. Standard of Self-Evaluation/Judgement Committee for Experimental Animal

    (September 4th, 2015)   

Certificate by the third party

Our laboratory animal facilities were stipulated by the Ministry of Health, Labour and Welfare based on the assessment by the Center for Accreditation of Laboratory Animal Care and Use, Japan Health Sciences Foundation on February 22nd, 2019.

Japanese

Medium-term Carcinogenesis Bioassay/Safety Assessment for Developing Products

DIMS Institute of Medical Science, Inc.

64 Goura, Nishiazai,
Azai-cho, Ichinomiya,
Aichi 491-0113, Japan

Tel: +81-586-51-1201
Fax: +81-586-51-5634

Company Profile

Mobile site

DIMS Institute of Medical Science, Inc.スマホサイトQRコード

Access to the mobile site of DIMS. from this QR code.